Literature DB >> 6488173

Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.

T Suga, T Shiio, Y Y Maeda, G Chihara.   

Abstract

The antitumor effect of lentinan in syngeneic and autochthonous tumor-host systems and its suppressive effect on 3-methylcholanthrene (MC)-induced carcinogenesis were confirmed using DBA/2 and SWM/Ms hosts. The regressive activity of lentinan against the solid form of Sarcoma 180 was the most effective in DBA/2, SWM/Ms, or A/J mice and less effective in C3H/He or C57BL/6 mice. The growth of a syngeneic MC-induced DBA/2.MC.CS-1 fibrosarcoma (native and trypsinized) was markedly inhibited, and the regression of tumors was detected by the i.p. injection of minute amounts of lentinan into DBA/2 mice, which were the most suitable host in lentinan treatment. When DBA/2 mice were used, lentinan was also effective for even autochthonous primary tumors induced within 15 weeks after MC inoculation, but less effective for tumors induced during the 16 to 36 weeks after MC treatment. Lentinan showed a prominent suppressive effect in MC-induced carcinogenesis using DBA/2 and SWM/Ms mice but not effect when BALB/c, C57BL/6, or C3H/He mice were used. The timing of lentinan administration in the latter result was examined using SWM/Ms mice, and lentinan, when it was given daily for 10 days after the third week of MC inoculation, was strikingly effective (33%), but not so effective (63%) when lentinan was given after the sixth week of MC treatment, compared with tumor-occurrence rate in the control group (88%). The reason why DBA/2, SWM/Ms, or A/J mice were suitable hosts for lentinan treatment is not clear, but the natural killer capability or phagocytic macrophage function in these strains seems to have no relation to lentinan action, because A/J mice are deficient in natural killer function, and in these strains of mice the phagocytic function of macrophages is weak. It may be quite possible that these strains of mice are most sensitive to delayed-type hypersensitivity and/or cytotoxic T-cell response in which T-cells and lentinan play important roles. The tumor-host systems presented here provide a good model in which lentinan retains an inhibitory capacity in syngeneic and autochthonous hosts, and such a model offers the possibility for further study of the host defense mechanism against cancer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488173

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases.

Authors:  K Yamasaki; S Sone; T Yamashita; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers.

Authors:  J E Talmadge; M A Chirigos
Journal:  Springer Semin Immunopathol       Date:  1985

3.  β-Glucan from Lentinus edodes inhibits nitric oxide and tumor necrosis factor-α production and phosphorylation of mitogen-activated protein kinases in lipopolysaccharide-stimulated murine RAW 264.7 macrophages.

Authors:  Xiaojuan Xu; Michiko Yasuda; Sachiko Nakamura-Tsuruta; Masashi Mizuno; Hitoshi Ashida
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

4.  Update on the immunomodulating activities of glucans.

Authors:  N R Di Luzio
Journal:  Springer Semin Immunopathol       Date:  1985

5.  In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Authors:  M Tani; H Tanimura; H Yamaue; M Iwahashi; T Tsunoda; M Tamai; K Noguchi; K Arii
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Oncostatic and immunomodulatory effects of a glycoprotein fraction from water extract of abalone, Haliotis discus hannai.

Authors:  H Uchida; T Sasaki; N A Uchida; N Takasuka; Y Endo; H Kamiya
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.

Authors:  M Hosokawa; T Mizukoshi; K Morikawa; Z Y Xu; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Significant antitumor effect of a synthetic lipid A analogue, DT-5461, on murine syngeneic tumor models.

Authors:  E Kumazawa; A Tohgo; T Soga; T Kusama; Y Osada
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  Effect of lentinan combined with docetaxel and cisplatin on the proliferation and apoptosis of BGC823 cells.

Authors:  Li Zhao; Yuping Xiao; Nan Xiao
Journal:  Tumour Biol       Date:  2013-02-13

10.  Antitumour and immunological activity of a beta 1----3/1----6 glucan from Glomerella cingulata.

Authors:  K Gomaa; J Kraus; F Rosskopf; H Röper; G Franz
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.